ADAP - Adaptimmune Therapeutics: Still The TCR Leader And With Major Upcoming Catalysts June, 16 2021 08:00 AM Adaptimmune Therapeutics plc I covered Adaptimmune in December. This article covers all that has changed since then. A BLA filing next year could be a major catalyst. For further details see: Adaptimmune Therapeutics: Still The TCR Leader, And With Major Upcoming Catalysts